OPKO Health, Inc.'s (OPK) company, ModeX Therapeutics Inc., was awarded 35millionofadditionalfundingunderanexistingcontractwiththeBiomedicalAdvancedResearchandDevelopmentAuthority(BARDA),partoftheAdministrationforStrategicPreparednessandResponseattheU.S.DepartmentofHealthandHumanServicesonMonday.ThefundingbringsthetotalsupportawardedtoModeXto110 million out of $205 million if all options are executed. The funding is expected to support the development of a s ...